Whitehawk Therapeutics, Inc. Balance Sheet
WHWK|8 years of annual SEC 10-K data (FY2018-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 8 fiscal years. All figures from audited SEC 10-K filings.
Whitehawk Therapeutics, Inc. had $151M in total assets and $52M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37.6M | $28.7M | $62.9M | $39.0M | $149.0M | $42.6M | $38.5M | $20.3M |
| Accounts Receivable | - | $5.9M | $5.5M | $1.9M | - | - | - | - |
| Inventory | - | $5.3M | $6.4M | $1.9M | - | - | - | - |
| Current Assets | $149.0M | $61.3M | $124.6M | $180.0M | $151.3M | $44.7M | $39.6M | $64.0M |
| PP&E (Net) | $3.0K | $6.8M | $4.8M | $508.0K | $57.0K | $121.7K | $164.2K | $98.4K |
| Total Assets | $150.8M | $70.3M | $132.4M | $184.2M | $157.9M | $44.9M | $39.9M | $64.1M |
| Current Liabilities | $14.5M | $17.1M | $26.4M | $18.8M | $15.3M | $1.9M | $3.3M | $5.5M |
| Shareholders' Equity | $52.5M | $105.2M | $158.4M | $136.4M | -$12.4M | $36.5M | $58.7M | $17.4M |